- Email: [email protected]
Osmoflo gears up to help industry reuse its water
NEWS
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: David Hopwood Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas Email: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Progenta Llp), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1401 for all European countries & Iran US$1570 for all countries except Europe and Japan ¥186 100 for Japan (Prices valid until 31 December 2014) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Companies explore opportunities in Nigeria’s water sector
S
ingapore’s Hyflux Ltd, through its wholly-owned subsidiary Hyflux International Pte Ltd (HIPL), has signed a joint-venture agreement with Tolaram Corp Pte Ltd to explore opportunities for the development of membrane-based water treatment plants in Nigeria. As part of this agreement a Singapore-registered company called Yewa Water Co Pte Ltd has been established. HIPL and Tolaram hold equal equity stakes in this company. Yewa Water Co Pte Ltd, in turn, owns the majority stake in Yewa Water Co Ltd, a firm incorporated in Nigeria that will undertake water projects in the country. Tolaram is a Singapore-based multi-industry company engaged in food, paper and packaging, textiles, energy, logistics and real estate businesses. Its interests span Singapore, India, Indonesia, Nigeria, Estonia and Ghana. In Nigeria, Tolaram is involved in the distribution of food products and provision of logistics services, as well as the development of infrastructure projects. Contacts: Hyflux Ltd, Hyflux Innovation Centre, 80 Bendemeer Road, Singapore 339949. Tel: +65 6214 0777, www.hyflux.com Tolaram Corp Pte Ltd, 1A International Business Park 12–02, Singapore 609933. Tel: +65 6387 7777, Fax: +65 6327 9782, www.tolaram.com
Osmoflo gears up to help industry reuse its water
A
ustralian desalination company Osmoflo Pty Ltd has formed a wastewater business in response to increasing demand from industry at large and the utilities sector for efficient treatment systems that maximise the potential for reusing water. The company, which designs, constructs, commissions and operates reverse osmosis (RO) treatment plants that deliver reclaimed water, says the new business offers the full range of wastewater treatment systems in addition to membrane-based technologies. Flexibility extends to contract options that include engineering pro-
curement and construction (EPC), design build operate and maintain (DBOM), build own operate (BOO), rental and commercial lease. Osmoflo’s wastewater business is based at the company’s manufacturing facility in Burton, South Australia, with technical representatives located at the firm’s offices throughout Australia. The head of the business Jamie Roodenrys joined Osmoflo in 2012 and has more than 20 years of experience in local government, asset management, and water and wastewater, including seven years in the Middle East participating in the delivery of major wastewater projects. ‘Osmoflo has wide Australian and international experience in providing plants enabling the reuse or the discharge of treated water in full compliance with regulatory standards. However, the new business signifies a dedicated approach, within the company, to wastewater management – one that we believe industry has come to expect from providers of water solutions,’ commented Roodenrys. ‘Demand for reuse is being driven by growing community and industry expectations relating to sustainable, cost-effective and reliable wastewater treatment, coupled with the implementation of increasingly stringent regulatory standards, particularly relating to environmental discharge. These factors are bringing about a renewed focus on all aspects of wastewater treatment and recycling.’ Contact: Osmoflo Pty Ltd, 382 Diment Road, Burton, 5110, South Australia, Australia. Tel: +61 8 8282 9700, www.osmoflo.com
Dow and Haier reach new agreement on Filmtec RO components
D
ow Water & Process Solutions (DW & PS), a business unit of Dow Chemical Co, has celebrated the first anniversary of its water purification business arrangement with Haier Group. Meanwhile, a new collaboration agreement between the two parties has also been agreed. ‘The cooperation between Haier and DW & PS worked out very well over the last year, and we look forward to continuing our collaboration to provide safer, healthier drinking water to China,’ said Lance Johnson, Asia Pacific Commercial Director, DW & PS (also see Membrane Technology May 2013, page 6).
May 2014
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: David Hopwood Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas Email: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Progenta Llp), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1401 for all European countries & Iran US$1570 for all countries except Europe and Japan ¥186 100 for Japan (Prices valid until 31 December 2014) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Companies explore opportunities in Nigeria’s water sector
S
ingapore’s Hyflux Ltd, through its wholly-owned subsidiary Hyflux International Pte Ltd (HIPL), has signed a joint-venture agreement with Tolaram Corp Pte Ltd to explore opportunities for the development of membrane-based water treatment plants in Nigeria. As part of this agreement a Singapore-registered company called Yewa Water Co Pte Ltd has been established. HIPL and Tolaram hold equal equity stakes in this company. Yewa Water Co Pte Ltd, in turn, owns the majority stake in Yewa Water Co Ltd, a firm incorporated in Nigeria that will undertake water projects in the country. Tolaram is a Singapore-based multi-industry company engaged in food, paper and packaging, textiles, energy, logistics and real estate businesses. Its interests span Singapore, India, Indonesia, Nigeria, Estonia and Ghana. In Nigeria, Tolaram is involved in the distribution of food products and provision of logistics services, as well as the development of infrastructure projects. Contacts: Hyflux Ltd, Hyflux Innovation Centre, 80 Bendemeer Road, Singapore 339949. Tel: +65 6214 0777, www.hyflux.com Tolaram Corp Pte Ltd, 1A International Business Park 12–02, Singapore 609933. Tel: +65 6387 7777, Fax: +65 6327 9782, www.tolaram.com
Osmoflo gears up to help industry reuse its water
A
ustralian desalination company Osmoflo Pty Ltd has formed a wastewater business in response to increasing demand from industry at large and the utilities sector for efficient treatment systems that maximise the potential for reusing water. The company, which designs, constructs, commissions and operates reverse osmosis (RO) treatment plants that deliver reclaimed water, says the new business offers the full range of wastewater treatment systems in addition to membrane-based technologies. Flexibility extends to contract options that include engineering pro-
curement and construction (EPC), design build operate and maintain (DBOM), build own operate (BOO), rental and commercial lease. Osmoflo’s wastewater business is based at the company’s manufacturing facility in Burton, South Australia, with technical representatives located at the firm’s offices throughout Australia. The head of the business Jamie Roodenrys joined Osmoflo in 2012 and has more than 20 years of experience in local government, asset management, and water and wastewater, including seven years in the Middle East participating in the delivery of major wastewater projects. ‘Osmoflo has wide Australian and international experience in providing plants enabling the reuse or the discharge of treated water in full compliance with regulatory standards. However, the new business signifies a dedicated approach, within the company, to wastewater management – one that we believe industry has come to expect from providers of water solutions,’ commented Roodenrys. ‘Demand for reuse is being driven by growing community and industry expectations relating to sustainable, cost-effective and reliable wastewater treatment, coupled with the implementation of increasingly stringent regulatory standards, particularly relating to environmental discharge. These factors are bringing about a renewed focus on all aspects of wastewater treatment and recycling.’ Contact: Osmoflo Pty Ltd, 382 Diment Road, Burton, 5110, South Australia, Australia. Tel: +61 8 8282 9700, www.osmoflo.com
Dow and Haier reach new agreement on Filmtec RO components
D
ow Water & Process Solutions (DW & PS), a business unit of Dow Chemical Co, has celebrated the first anniversary of its water purification business arrangement with Haier Group. Meanwhile, a new collaboration agreement between the two parties has also been agreed. ‘The cooperation between Haier and DW & PS worked out very well over the last year, and we look forward to continuing our collaboration to provide safer, healthier drinking water to China,’ said Lance Johnson, Asia Pacific Commercial Director, DW & PS (also see Membrane Technology May 2013, page 6).
May 2014